Filing Details
- Accession Number:
- 0001104659-21-086828
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-06-29 16:07:21
- Reporting Period:
- 2021-06-29
- Accepted Time:
- 2021-06-29 16:07:21
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1783032 | Elevation Oncology Inc. | ELEV | Biological Products, (No Disgnostic Substances) (2836) | 841771427 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1868847 | Ltd. Pte. Ii Fund Hc Global Vertex | 250 North Bridge Road #11-01 Raffles City Tower Singapore U0 179101 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-06-29 | 1,656,577 | $0.00 | 1,656,577 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2021-06-29 | 401,065 | $0.00 | 2,057,642 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2021-06-29 | 250,000 | $16.00 | 2,307,642 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Direct | |
| No | 4 | C | Direct | |
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Series A Convertible Preferred Stock | Disposition | 2021-06-29 | 7,000,000 | $0.00 | 1,656,577 | $0.00 |
| Common Stock | Series B Convertible Preferred Stock | Disposition | 2021-06-29 | 1,694,730 | $0.00 | 401,065 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct |
Footnotes
- Each share of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock will automatically convert into Common Stock immediately on a 4.225582-for-one basis (4.225582 shares of preferred stock will convert into 1 share of Common Stock) prior to the closing of the Issuer's initial public offering, and has no expiration date.
Billionaire Hedge Funds
